MEGAN GLENN: Open Payments
NPI 1427328798 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,026 in 88 payments from 15 companies in 2025. Trend: 2023 $1,562 · 2024 $2,282 · 2025 $2,026
Food & beverage: $1,907Education: $119
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $475 |
| ABBVIE INC. | 14 | $267 |
| PFIZER INC. | 14 | $261 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $201 |
| Lilly USA, LLC | 6 | $159 |
| GENZYME CORPORATION | 4 | $128 |
| Regeneron Healthcare Solutions, Inc. | 4 | $116 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
| Organon LLC | 11 | $108 |
| Smith+Nephew, Inc. | 1 | $51 |
Products named: Bimzelx, CIBINQO, SKYRIZI, DUPIXENT, TALTZ, RINVOQ, ILUMYA, VTAMA.
Industry payments across IL — which companies pay providers there.
